COST-EFFECTIVENESS OF EMICIZUMAB VERSUS BY-PASSING AGENTS...

HemaSphere 2019 / 06 Vol. 3

COST-EFFECTIVENESS OF EMICIZUMAB VERSUS BY-PASSING AGENTS IN PATIENTS WITH HAEMOPHILIA A AND FVIII INHIBITORS IN FRANCE

Polack, B., Trossaert, M., Godard, C., Cousin, M., Baffert, S., Pruvot, A., Pinguet, J.-M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
3
Journal:
HemaSphere
DOI:
10.1097/01.hs9.0000559536.51337.44
Date:
June, 2019
File:
PDF, 535 KB
2019
Conversion to is in progress
Conversion to is failed